Cytokine effect on fibronectin release by retinal pigment epithelial cells.

Because fibronectin (FN) is known to be present in membranes in proliferative vitreoretinopathy, we sought to identify cytokines that regulate the release of FN by retinal pigment epithelial cells (RPE). Levels of FN in the supernatant of cultured human RPE cells were quantified with an ELISA, after which the cells were stimulated with human recombinant cytokines, interleukin-1 beta (IL-1 beta), tumor necrosis factor alpha (TNF alpha), interleukin-6 (IL-6), interferon gamma (IFN-gamma), transforming growth factor beta 1 and 2 (TGF-beta), and phorbol myristate acetate (PMA). Protein kinase C (PKC) was blocked by 2 nM calphostin C or 1 mM staurosporine. RPE cells released FN into the supernatant constitutively. TGF-beta 1 and TGF-beta 2 upregulated the FN release in a dose- and time-dependent manner. The other cytokines tested were without effect. In combination, IFN-gamma and IL-1 beta reduced the effect of TGF-beta. PMA, which is a PKC activator, also increased the release of FN in a dose-dependent manner. Blocking of PKC with specific inhibitors abolished the effects of TGF-beta and PMA. The results show that TGF-beta is a potent stimulator of FN release by RPE cells, and exerts its effects via signal transduction involving PKC. Its effect is reduced by IFN-gamma.

[1]  F. DeRubertis,et al.  Role for Protein Kinase C in the Mediation of Increased Fibronectin Accumulation by Mesangial Cells Grown in High-Glucose Medium , 1993, Diabetes.

[2]  S. Wu,et al.  Expression of growth factor mRNA in rabbit PVR model systems. , 1992, Current eye research.

[3]  M. Odenthal,et al.  Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. , 1992, Gastroenterology.

[4]  Z. Gregor,et al.  Fibronectin synthesis in subretinal membranes of proliferative vitreoretinopathy. , 1992, The British journal of ophthalmology.

[5]  G. A. Limb,et al.  Cytokines in proliferative vitreoretinopathy , 1991, Eye.

[6]  T. Acott,et al.  Expression of matrix metalloproteinases and inhibitor by human retinal pigment epithelium. , 1990, Investigative ophthalmology & visual science.

[7]  A. Olsen,et al.  Interferon‐γ reverses the stimulation of collagen but not fibronectin gene expression by transforming growth factor‐ β in normal human fibroblasts , 1990 .

[8]  I. Grierson,et al.  Variation in epiretinal membrane components with clinical duration of the proliferative tissue. , 1990, The British journal of ophthalmology.

[9]  J. T. Thompson,et al.  RPE-mediated collagen gel contraction. Inhibition by colchicine and stimulation by TGF-beta. , 1990, Investigative ophthalmology & visual science.

[10]  D. Albert,et al.  Aqueous humor contains transforming growth factor-beta and a small (less than 3500 daltons) inhibitor of thymocyte proliferation. , 1990, Journal of immunology.

[11]  S. D. Bustros,et al.  Proliferative vitreoretinopathy membranes. An immunohistochemical study. , 1989, Ophthalmology.

[12]  L. Rasmussen,et al.  Quantification of fibronectin in extracts of human aortae by an ELISA. , 1989, Scandinavian journal of clinical and laboratory investigation.

[13]  M. Sporn,et al.  Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. , 1989, The Journal of clinical investigation.

[14]  M. Boulton,et al.  The cytoskeletal elements of human retinal pigment epithelium: in vitro and in vivo. , 1988, Journal of cell science.

[15]  V. Dixit,et al.  Modulation of keratinocyte motility. Correlation with production of extracellular matrix molecules in response to growth promoting and antiproliferative factors. , 1988, The American journal of pathology.

[16]  J. Vilček,et al.  A cytokine network in human diploid fibroblasts: interactions of beta-interferons, tumor necrosis factor, platelet-derived growth factor, and interleukin-1 , 1987, Molecular and cellular biology.

[17]  P. Campochiaro,et al.  Intravitreous fibronectin and platelet-derived growth factor. New model for traction retinal detachment. , 1986, Archives of ophthalmology.

[18]  P. Campochiaro,et al.  Serum contains chemoattractants for human retinal pigment epithelial cells. , 1984, Archives of ophthalmology.

[19]  J. Burke,et al.  Acid proteases of vitreal macrophages. , 1984, Current eye research.

[20]  I. Immonen,et al.  Retinal pigment epithelial cells secrete urokinase-type plasminogen activator and its inhibitor PAI-1. , 1992, Ophthalmic research.

[21]  G. Duncker,et al.  Postmortale serologische und biochemische HLA-Typisierung mit kultivierten retinalen Pigmentepithelzellen (RPE) , 1991 .

[22]  P. Wiedemann,et al.  Vitronektin- und Fibronektinrezeptoren bei proliferativen Netzhauterkrankungen , 1990 .

[23]  K. Onozaki,et al.  Regulation of fibronectin synthesis by interleukin-1 and interleukin-6 in rat hepatocytes. , 1990, The American journal of pathology.

[24]  G. Coscas,et al.  [Transforming growth factor beta in the vitreous of patients with epiretinal proliferation]. , 1990, Ophtalmologie : organe de la Societe francaise d'ophtalmologie.

[25]  M. Opas,et al.  Effects of TGF-beta on retinal pigmented epithelium in vitro. , 1989, Experimental cell biology.

[26]  M. Matsumura,et al.  Retinal pigment epithelial cells produce fibronectin. , 1987, Ophthalmic research.